Intra-Cellular Therapies (ITCI.MX) Q3 2024 Earnings

7AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-9.82
-7.45
-5.08
-2.7

Details

Expected EPS
-3.6541769263499995
Actual EPS
-3.073368
Surprise EPS
0.58
Surprise Percent
+15.89%

Description

Intra-Cellular Therapies (ITCI.MX) has reported earnings of -3.073368 per share for Q3 2024.

0 Comments

Share your thoughts